Human cardiac gap-junction coupling: Effects of antiarrhythmic peptide AAP10

Cardiovascular Research

Volumn 83, Issue 2, 2009, Pages 405-415

  Hagen, Anja ^a,b   Dietze, Anna ^a   Dhein, Stefan ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

AAP10; Antiarrhythmic peptide; Dual whole cell voltage clamp; Gap junctions; Human cardiomyocytes

Indexed keywords

AAP 10; ANTIARRHYTHMIC PEPTIDE; ANTIARRHYTHMIC PEPTIDE AAP 10; CARBON DIOXIDE; CONNEXIN 40; CONNEXIN 43; CONNEXIN 45; LUCIFER YELLOW; UNCLASSIFIED DRUG;

ACIDIFICATION; ACIDOSIS; ANIMAL CELL; ARTICLE; CELL COMMUNICATION; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CELL METABOLISM; CELL PH; CONCENTRATION RESPONSE; CONTROLLED STUDY; GAP JUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION SYSTEM; HELA CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VOLTAGE CLAMP; WESTERN BLOTTING; WHOLE CELL;

ACIDOSIS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CARBON DIOXIDE; CELL MEMBRANE PERMEABILITY; CONNEXIN 43; CONNEXINS; ELECTRIC CONDUCTIVITY; GAP JUNCTIONS; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; MYOCYTES, CARDIAC; OLIGOPEPTIDES; PATCH-CLAMP TECHNIQUES; RATS; SODIUM; TIME FACTORS; TRANSFECTION;

EID: 67650266546     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp028     Document Type: Article

References (47)

1. Camelliti P, Green CR, Kohl P. Structural and functional coupling of cardiac myocytes and fibroblasts. Adv. Cardiol. 2006;42:132-149.
2. de Groot JR, Wilms-Schopman FJ, Opthof T, Remme CA, Coronel R. Late ventricular arrhythmias during acute regional ischemia in the isolated blood perfused pig heart. Role of electrical cellular coupling. Cardiovasc. Res. 2001;50:362-372.
3. Smith WT IV, Fleet WF, Johnson TA, Engle CL, Cascio WE. The Ib phase of ventricular arrhythmias in ischemic in situ porcine heart is related to changes in cell-to-cell electrical coupling. Experimental Cardiology Group, University of North Carolina. Circulation 1995;92:3051-3060.
4. Dhein S, Manicone N, Müller A, Gerwin R, Ziskoven U, Irankhahi A et al. A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. Naunyn-Schmiedebergs Arch. Pharmacol. 1994;350:174-184.
5. Grover R, Dhein S. Spatial structure determination of antiarrhythmic peptide using nuclear magnetic resonance spectroscopy. Peptides 1998; 19:1725-1729.
6. Weng S, Lauven M, Schaefer T, Polontchouk L, Grover R, Dhein S. Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation. FASEBJ. 2002;16:1114-1116.
7. Xing D, Kjoølbe AL, Nielsen MS, Petersen JS, Harlow KW, Holstein-Rathlou NH et al. ZP123 increases gap junctional conductance and prevents reentrant ventricular tachycardia during myocardial ischemia in open chest dogs. J. Cardiovasc. Electrophysiol. 2003;14:510-520.
8. Müller A, Gottwald M, Tudyka T, Linke W, Klaus W, Dhein S. Increase in gap junction conductance by an antiarrhythmic peptide. Eur. J. Pharmacol. 1997;327:65-72.
9. Grover R, Dhein S. Structure-activity relationships of novel peptides related to the antiarrhythmic peptide AAP10 which reduce the dispersion of epicardial action potential duration. Peptides 2001;22:1011-1021.
10. Kjoølbye AL, Holstein-Rathlou NH, Petersen JS. Anti-arrhythmic peptide N-3-(4-hydroxyphenyl)propionyl Pro-Hyp-Gly-Ala-Gly-OH reduces dispersion of action potential duration during ischemia/reperfusion in rabbit hearts. J. Cardiovasc. Pharmacol. 2002;40:770-779.
11. Kjoølbye AL, Knudsen CB, Jepsen T, Larsen BD, Petersen JS. Pharmacological characterization of the new stable antiarrhythmic peptide analog Ac-D-Tyr-D-Pro-D-Hyp-Gly-D-Ala-Gly-NH2 (ZP123): in vivo and in vitro studies. J. Pharmacol. Exp. Ther. 2003;306:1191-1199.
12. Axelsen LN, Stahlhut M, Mohammed S, Larsen BD, Nielsen MS, Holstein-Rathlou NH et al. Identification of ischemia-regulated phos- phorylation sites in connexin43: a possible target for the antiarrhythmic peptide analogue rotigaptide (ZP123). J. Mol. Cell. Cardiol. 2006;40: 790-798.
13. Clarke TC, Thomas D, Petersen JS, Evans WH, Martin PE. The anti- arrhythmic peptide rotigaptide (ZP123) increases gap junction intercellular communication in cardiac myocytes and HeLa cells expressing connexin 43. Br. J. Pharmacol. 2006;147:486-495.
14. Lin X, Zemlin C, Hennan JK, Petersen JS, Veenstra RD. Enhancement of ventricular gap-junction coupling by rotigaptide. Cardiovasc. Res. 2008;79:416-426.
15. Schulte JS, Scheffler A, Rojas-Gomez D, Mohr FW, Dhein S. Neonatal rat cardiomyocytes show characteristics of non-homotypic gap junction channels. Cell Commun. Adhes. 2008;15:13-25.
16. Rastan AJ, Dhein S. Recording gap junction currents. In: Dhein S, Mohr FW, Delmar M eds., Practical Methods in Cardiovascular Research. Heidelberg, Germany: Springer-Verlag; 2005. p397-416.
17. Müller A, Lauven M, Berkels R, Dhein S, Polder HR, Klaus W. Switched single-electrode voltage-clamp amplifiers allow precise measurement of gap junction conductance. Am. J. Physiol. 1999;276:C980-C987.
18. Rae J, Cooper K, Gates P, Watsky M. Low access resistance perforated patch recordings using amphotericin B. J. Neurosci. Methods 1991;37: 15-26.
19. Spray DC, Harris AL, Bennett MVL. Equilibrium properties of a voltage dependent junctional conductance. J. Gen. Physiol. 1981;77:77-93.
20. Kwak BR, Jongsma HJ. Regulation of cardiac gap junction channel permeability and conductance by several phosphorylating conditions. Mol. Cell. Biochem. 1996;157:93-99.
21. El-Fouly MH, Trosko JE, Chang CC. Scrape-loading and dye transfer. Exp. Cell Res. 1987;168:422-430.
22. Doble BW, Chen Y, Bosc DG, Litchfield DW, Kardami E. Fibroblast growth factor-2 decreases metabolic coupling and stimulates phosphorylation as well as masking of connexin43 epitopes in cardiac myocytes. Circ. Res.1996; 79:647-658.]
23. Lalevée N, Nargeot J, Barrére-Lemaire S, Gautier P, Richard S. Effects of amiodarone and dronedarone on voltage-dependent sodium current in human cardiomyocytes. J. Cardiovasc. Electrophysiol. 2003;14:885-890.
24. Noma A, Tsuboi N. Dependence of junctional conductance on proton, calcium and magnesium ions in cardiac paired cells of guinea pig. J. Physiol. (Lond) 1987;382:193-211.
25. Liu S, Taffet S, Stoner L, Delmar M, Vallano ML, Jalife J. A structural basis for the unequal sensitivity of the major cardiac and liver gap junctions to intracellular acidification: the carboxy tail length. Biophys. J. 1993;64: 1422-1433.
26. Morley GE, Taffet SM, Delmar M. Intramolecular interactions mediate pH regulation of connexin 43 channels. Biophys. J. 1996;70:1294-1302.
27. Ek JF, Delmar M, Perzova R, Taffet SM. Role of histidine 95 on pH gating of the cardiac gap junction protein connexin43. Circ. Res. 1994;74:1058-1064.
28. Hermans MMP, Kortekaas P, Jongsma HJ, Rook MB. pH sensitivity of the cardiac gap junction proteins, connexin 45 and 43. Pflǘs Arch. 1995; 431:138-140.
29. Duffy HS, Ashton AW, ÓDonnell P, Coombs W, Taffet SM, Delmar M et al. Regulation of connexin43 protein complexes by intracellular acidification. Circ. Res. 2004;94:215-222.
30. Lau AF. c-Src: bridging the gap between phosphorylation- and acidification-induced gap junction channel closure. Sci. STKE 2005;291: e33. p.
31. Haugan K, Olsen KB, Hartvig L, Petersen JS, Holstein-Rathlou NH, Hennan JK et al. The antiarrhythmic peptide analog ZP123 prevents atrial conduction slowing during metabolic stress. J. Cardiovasc. Electrophysiol. 2005;16:537-545.
32. Jozwiak J, Dhein S. Local effects and mechanisms of antiarrhythmic peptide AAP10 in acute regional myocardial ischemia: electrophysiologi- cal and molecular findings. Naunyn Schmiedebergs Arch. Pharmacol. 2008;378:459-470.
33. Eloff BC, Gilat E, Wan X, Rosenbaum DS. Pharmacological modulation of cardiac gap junctions to enhance cardiac conduction. Evidence supporting a novel target for anti-arrhythmic therapy. Circulation 2003;108: 3157-3163.
34. Kjolbye AL, Dikshteyn M, Eloff BC, Deschênes I, Rosenbaum DS. Maintenance of intercellular coupling by the antiarrhythmic peptide rotigaptide suppresses arrhythmogenic discordant alternans. Am. J. Physiol. 2008; 294:H41-H49.
35. Shiroshita-Takeshita A, Sakabe M, Haugan K, Hennan JK, Nattel S. Model- dependent effects of the gap junction conduction-enhancing anti- arrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs. Circulation 2007;115:310-318.
36. Haugan K, Miyamoto T, Takeishi Y, Kubota I, Nakayama J, Shimojo H et al. Rotigaptide (ZP123) improves atrial conduction slowing in chronic volume overload-induced dilated atria. Basic Clin. Pharmacol. Toxicol. 2006;99:71-79.
37. Haugan K, Kjolbye AL, Hennan JK, Petersen JS. Rotigaptide (ZP123) reverts established atrial conduction velocity slowing. Cell Commun. Adhes. 2005;12:271-278.
38. Kwak BR, van Veen TAB, Analbers LJS, Jongsma HJ. TPA increases conductance but decreases permeability in neonatal rat cardiomyocytes gap junction channels. Exp. Cell Res. 1995;220:456-463.
39. Bedner P, Niessen H, Odermatt B, Willecke K, Harz H. A method to determine the relative cAMP permeability of connexin channels. Exp. Cell Res. 291:25-35. 200.
40. Kanno S, Kovacs A, Yamada KA, Saffitz JE. Connexin43 as a determinant of myocardial infarct size following coronary occlusion in mice. J. Am. Coll. Cardiol. 2003;41:681-686.
41. Yasui K, Kada K, Hojo M, Lee JK, Kamiya K, Toyama J et al. Cell-to-cell interaction prevents cell death in cultured neonatal rat ventricular myo- cytes. Cardiovasc. Res. 2000;48:68-76.
42. Loewenstein WR. Permeability of membrane junctions. NY Acad. Sci. 1966;137:441-472.
43. Severs NJ, Dupont E, Thomas N, Kaba R, Rothery S, Jain R et al. Alterations in cardiac connexin expression in cardiomyopathies. Adv. Cardiol. 2006;42:228-242.
44. Moreno AP, Laing JG, Beyer EC, Spray DC. Properties of gap junction channels formed of connexin 45 endogenously expressed in human hepa-toma (SKHep1) cells. Am. J. Physiol. 1995;268:C356-C365.
45. Beblo DA, Wang HZ, Beyer BC, Westphale EM, Veenstra RD. Unique conductance, gating, and selective permeability properties of gap junction channels formed by connexin40. Circ. Res. 1995;77:813-822.
46. Ebihara L. Expression of dog connexin 40 and 45 in paired Xenopus oocytes. In: Kanno Y, Kataoka K, Shiba Y, Shibata Y, Shimazu T, eds., Intercellular Communication through Gap Junctions Progress in Cell Research. Vol. 4. Amsterdam, Holland: Elsevier Science Publishers; 1995. p395-398.
47. Polontchouk LO, Valiunas V, Haefliger JA, Eppenberger HM, Weingart R. Expression and regulation of connexins in cultured ventricular myocytes isolated from adult rat hearts. Pflugers Arch. 2002;443:676-689.